ACA Müller to Buy Healthcare Cannabis from MJardin Group


DENVER and TORONTO – MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announces a provide contract with ACA Müller ADAG Pharma Vertriebs GmbH (“ACA Müller”), a subsidiary of Franchise Cannabis Corp. (“Franchise”), for the provide offtake of a total of two,250 kg of health-related cannabis more than a nine month period in 2020 from MJardin’s 48,000 square foot Halifax facility (“AMI”)*. ACA Müller has committed to buy 250 kgs a month of higher THC (&gt20%) health-related cannabis flower for the duration of Q1 to Q3 2020 at a set price tag all through the year. AMI remains on track for EU GMP Certification by the finish of this year and is anticipated to add an further 20,000 square feet by Q1 2020.

“This agreement is a essential milestone for MJardin and AMI as it represents our very first sales outdoors of North America,” stated Pat Witcher, COO of Mjardin. “Entering into the European industry enables MJardin to attain premium pricing in new markets for around half of the month-to-month production at AMI and is the starting of developing out a very important new geographic industry for distribution. We appear forward to operating with Franchise as our European distribution companion in this higher development area.”


“MJardin has constructed a reputation as an operator with a major cultivation group. The Halifax facility is genuinely globe class and fits with our strict high quality requirements. This provide connection will enable us to improve our sales volumes to meet increasing demand,” stated Clifford Starke, Franchise Cannabis’s CEO. “The German industry added 20,000 new individuals final quarter, and our inventories are getting sold out month immediately after month. We appear forward to operating with AMI and MJardin as we continue to develop industry share across pharmacy networks in the jurisdiction with the highest price tag per gram in the globe.”

“We are excited for this partnership with Franchise and what it will bring to MJardin and AMI. Connecting with European markets, in this market, is a milestone for the Mi’kmaq of Nova Scotia and we appear forward to furthering our international relationships,” stated Chief Mike Sack, Assembly of Nova Scotia Mi’kmaw Chiefs.

*AMI is a 3-way partnership consisting of the Nova Scotia Mi’kmaq Very first Nations (51%), MJardin Group, Inc. (39%) and yet another minority shareholder.

About MJardin Group
MJardin is a cannabis management platform with in depth encounter in cultivation, processing, distribution and retail. For more than 10 years, MJardin has refined cultivation methodologies, created state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is primarily based in Denver, Colorado and Toronto, Canada.

About Franchise Cannabis Corp.
Franchise Cannabis is a worldwide, totally integrated health-related cannabis firm with a major German distribution platform constructed upon the very first license granted in March 2017. With two distribution facilities in Germany serving a vast pharmacy network, a licensed cultivator in Denmark at the moment generating higher high quality health-related cannabis, and provide relationships with prestigious cannabis groups globally, Franchise is on the cutting edge of the European health-related cannabis industry. Franchise also has a single of the most full and sought-immediately after genetics collections in the globe with more than 220 strains, a lot of of which have won Cannabis Cups and also has licensed CBD cultivation and extraction operations in Colombia and Uruguay.


Latest posts